OKYO Pharma Limited Sponsored ADR's total assets for Q2 2026 were $4.64M, an increase of 26.28% from the previous quarter. OKYO total liabilities were $8.06M for the fiscal quarter, a -12.66% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.